The diagnosis of mutations that are responsible for human genetic diseases is important, and several molecular biology techniques based on polymerase chain reaction (PCR) (1), have been specially developed for this purpose (2-8). For some of these techniques it is the presence or the absence of a PCR product that constitutes the analytical step, ie proves the presence of the mutation. In order to discriminate between wild-type and mutant alleles, the analytical PCR requires specific and adapted PCR conditions for each mutation studied (concentration of each PCR primers set, temperature of hybridization, concentration of MgClJ. Consequently, conditions must be continually adapted for the study of several different mutations. However when a mutation creates or destroys a natural or an artificial (5 -8) restriction site then PCR-RFLP is usually used to diagnose the mutation despite all other available diagnostic techniques. However PCR-RFLP presents a technical difficulty since a defective restriction enzyme activity can be confused with the loss of the restriction site. Thus, it has been recommended that PCR products are digested in the presence of an excess of restriction enzyme for a long period of time (8). Despite these precautions, the presence of a restriction site is experimentally easier to ascertain than its absence. In order to overcome this difficulty, we have developed a method which we call the PCR double RFLP (PCR-dRFLP). For each studied DNA, two modified nested PCRs are performed at the same time, one pair of PCR primers is designed to introduce a restriction site specific for the wild-type allele while the second pair of primers is designed to introduce a restriction site specific for the mutant allele. Each PCR product is then analyzed by RFLP. These two RFLP allow an unambiguous interpretation of the results. Essentially, it is as though each mutation abolished a restriction site on the wild-type sequence to create a new one on the mutant sequence. Furthermore, the PCR-dRFLP was developed in a manner which allows all studied mutations to be processed with a unique procedure.
A summary of the method used is presented in Figure 1 . Nested primers were selected so that the nested PCR gives an amplification product of approximately 90 bp for all mutations studied. Nested primers used to construct restriction sites border the site of the mutation. The interpretation of results of PCRdRFLP is then always dependent upon the presence of a restriction product that has an expected size of approximately 70 bp. The Wp and Mp PCR products are 90 bp long before digestion and are cleaved to 70 and 20 bp fragments upon digestion with the appropriate restriction enzyme. By convention, for each studied DNA, the Wp product digested by the enzyme ErW is displayed in lane w arid the Mp product digested by the enzyme ErM is displayed in lane m of the gels. Cleavage of Wp hcmoxypoto mutant to* hetarozy^ote Figure 1 . Summary of the PCR-dRFLP. The forward (pf) and backward (pb) primers used to amplify the region that surrounds the mutation were chosen by the Octamer Frequency Disparity (OFD) method (9) with the PC-RARE software (Eurogentec, Seraing, Belgium).For each mutation studied, the nested primer used to create a restriction site on the wild-type sequence is identified by pnfw (primer nested forward wild-type) and the nested primer used to create a restriction site on the mutant sequence is identified by pnfm (primer nested forward mutant). Nested primers which are situated within 50 bp of the studied mutation, and whose sequence is common to both wild-type and mutant DNA are identified by pnbC (primer nested backward Common). PCR primers pf and pb are included in the 'First mix' (Fimx) used at the first round of PCR (FPCR). The FPCR is undertaken in two different tubes, denoted as Wt (wild-type tube) and Mt (Mutant tube). Primers pnfW and pnbc are included in the 'wild-type nested mix' (Wmix) used in the 'wild-type nested PCR' (WPCR), the WPCR is executed in the Wt tube. The WPCR product (Wp) can be specifically cut by the restriction enzyme ErW. The nomenclature used for the mutant allele detection step (pnfM, Mmix, MPCR, Mp and ErM), is homologous to that used for the wild-type allele detection step. The nomenclature described above corresponds to the case where dose nested primers to the mutation are forward primers (this is the case described here). If these primers are backward primers, then the terminology is similarly: pnfC, pnbW and pnbM.
* To whom correspondence should be addressed A sequence where a GG on the wild-type allele is replaced by a C on the mutant allele is given as follows: (GG / Q. Sequences of primers are in upper case letters; mismatched bases arc in boW characters; lower case letters are sequences following the primer on the genomic DNA and are given to locate the restriction site (underlined). Restriction enzymes ErW and ErM are described for each mutation. (N13O3K and G551D) , wild-type DNAs (samples 11 and 13) and heterozygote DNAs (samples 12 and 14) were studied. For the AF5O8 mutation, three samples of DNA were studied: bomozygote wild-type, heterozygote and homozygote mutant (samples 15, 16 and 17 respectively).
by ErW indicates that a wild-type allele is present in the DNA sample. Similarly the existence of a 70bp band in the lane m indicates that a mutant allele is present in the sample. It should be noted that bands of 70 bp are specific restriction products, so that, the interpretation of results of the PCR-dRFLP is always based on a positive observation upon digestion.
All PCR mixes were prepared as follows: 0.5 /tM of each primer, 200 /tM of each dNTP, 50 mM KCL, 2 mM MgC12, 0.01% gelatine, in Tris 10 mM pH 8.4, with TAQ polymerase (Cetus) at 2U per 100 /tl. First PCR: 1 /tl of DNA (200 to 700 ng) was added to 50 /tl of Fmix. The DNA was homogenized gently by mixing 15 to 20 times with a pipette, then 3 /tl of this mix were transferred to the Wt PCR tube and a second aliquot of 3 fd was transferred to the Mt PCR tube, 50 /tl of mineral oil were added to each tube. Tubes were submitted to 30 cycles of amplification (Hybaid-OmniGene Temperature Cyclermode : tube control) as follows: 93°C 15 s, 55°C 75 s, 72°C 75 s. Reactions were then maintained at 72 °C for 10 min. Nested PCR: The tube Wt was then opened and 100 /tl of the Wmix were added above the mineral oil. One hundred /tl of the Mmix were identically transferred in the Mt tube. Tubes were centrifuged for 30 s and submitted to 30 rapid amplification cycles (93°C 15 s, 55°C 20 s). Tubes were finally maintained at 72°C for 10 min. Each PCR product (Wp and Mp) was then purified with the QIAquick-spin system (QIAGEN, Chats worth, CA, USA) using the conditions suggested by the manufacturer, except that DNA was eluted in 50 /tl of water. Seventeen /tl of the Wp and Mp PCR products were digested with 4 U of the restriction enzyme ErW and ErM respectively, in a final volume of 20 /tl. Loading buffer (4 /tl) was then added and 12 /tl of this mix were analysed on a 10% polyacrylamide gel (TBE 0.5 x, 100V 1H) in an LKB 2050 Midget Electrophoresis Unit. The gels were stained with ethidium bromide (1 /tg/ml) for 10 min, washed in water for 30 min and photographed.
We have adapted this approach to the diagnosis of eight human mutations, implied either in the X-linked Kallmann syndrome (10) or in cystic fibrosis (11) . The legend to Figure 2 describes the samples used in this study: all the results obtained with PCRdRFLP were in agreement with previous diagnoses.
For the eight mutations studied in this report, the PCR-dRFLP system gave unambiguous results. Compared to the numerous techniques previously described, PCR-dRFLP possesses several advantages; the technique is simple and very robust, it does not necessitate precise quantification of the studied DNA, and although nested PCR is used, there is no direct manipulation of the first PCR product. The interpretation of results is supported by the presence of either one or two restriction sites as a ftinction of the homozygotous or heterozygotous nature of the DNA being investigated. As a consequence, the two results obtained for a DNA allow the totally reliable diagnosis of the genotype of the sample studied.
Primers sequences and specific software used in this work are available on request.
